You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,945,960


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,945,960 protect, and when does it expire?

Patent 10,945,960 protects CONSENSI and is included in one NDA.

This patent has two patent family members in two countries.

Summary for Patent: 10,945,960
Title:Celecoxib and amlodipine formulation and method of making the same
Abstract: Provided herein is a celecoxib and amlodipine composition and method of making the same. The composition contains granules containing celecoxib. The amlodipine is incorporated into the composition as an extragranulate.
Inventor(s): Efrati; Yitshak Itsik (Modiin, IL)
Assignee: Dexcel Ltd. (Or-Akiva, IL) Kitov Pharmaceuticals (Tel Aviv, IL)
Application Number:16/427,499
Patent Claim Types:
see list of patent claims
Composition; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,945,960

Introduction

Patents are a crucial component of intellectual property, providing exclusive rights to inventors and innovators. The United States Patent 10,945,960, hereafter referred to as the '960 patent, is a significant example of how patents can protect innovative products and processes. This article delves into the scope, claims, and the broader patent landscape surrounding this patent.

Patent Overview

The '960 patent, owned or exclusively licensed by Purple Biotech, is part of a series of patents related to pharmaceutical products. Specifically, it pertains to the formulation and composition of certain drug products.

Nature of the Patent

The '960 patent falls under the category of utility patents, which are granted for new and useful processes, machines, manufactures, or compositions of matter, or any improvement thereof[4].

Claims of the '960 Patent

The claims of a patent are its most critical component, as they define the scope of protection granted to the inventor.

Independent and Dependent Claims

The '960 patent includes both independent and dependent claims. Independent claims stand alone and define the invention broadly, while dependent claims refer back to and further limit the independent claims. For example, Claim 1 of the '960 patent might describe the overall composition of the drug product, while subsequent claims might detail specific aspects such as dosage forms, active ingredients, or methods of administration[5].

Claim Language and Scope

The language used in the claims is precise and technical, ensuring that the patent scope is well-defined. The scope of the patent is determined by the breadth and clarity of these claims. Broader claims can provide wider protection but may face challenges in terms of validity and enforceability. Narrower claims, on the other hand, are more likely to be granted and upheld but offer less extensive protection[3].

Patent Landscape

Understanding the patent landscape is essential for navigating the complex world of intellectual property.

Related Patents

The '960 patent is part of a family of patents that include other related patents such as U.S. Patent Nos. 10,350,171, 9,408,837, and 10,925,835. These patents collectively protect various aspects of the drug products, including formulations, methods of use, and specific compositions[5].

Litigation and Enforcement

Patents like the '960 patent are often involved in litigation, particularly when generic manufacturers seek to enter the market. For instance, Lupin's filing of an Abbreviated New Drug Application (ANDA) with the FDA triggered a patent infringement action by Purple Biotech, highlighting the importance of these patents in protecting market exclusivity[5].

Valuation of Patents

The value of patents like the '960 patent can be substantial and is determined using various methods.

Cost, Income, and Market Approaches

The cost approach considers the development costs of the patent, the income approach evaluates future benefits, and the market approach looks at what similar patents have sold for. For example, the Google-Motorola deal, where Google acquired 24,500 patents for $12.5 billion, illustrates the significant value that patents can hold[1].

Patent Term and Expiration

The term of a patent is critical in understanding its lifespan and the period during which it provides exclusive rights.

Patent Term Calculation

In the United States, the term of a utility patent is generally 20 years from the effective filing date. However, adjustments such as Patent Term Adjustment (PTA) and Patent Term Extension (PTE) can affect the actual expiration date. For instance, the '356 patent in the Allergan case had its term adjusted due to PTA, impacting its expiration date[2].

Technological Trends and Patenting

The '960 patent is part of a broader trend in pharmaceutical and biotechnology patenting.

Technology Areas

The USPTO classifies patents into various technology areas, with electrical and mechanical engineering being prominent. However, patents in the chemical and pharmaceutical fields are also significant, reflecting the ongoing innovation in these sectors[4].

Global Patent Trends

Patenting trends are not limited to the United States but are part of a global landscape.

International Comparisons

The World Intellectual Property Organization (WIPO) provides a framework for international patent classification, allowing for comparisons across different countries. This helps in understanding global innovation patterns and the role of patents in various technological fields[4].

Challenges and Debates

The patent system faces ongoing debates and challenges, particularly regarding patent quality and scope.

Patent Quality and Scope

There is a concern about the quality and scope of patents, with some arguing that broader patents can stifle innovation. Metrics such as independent claim length and count are used to measure patent scope, and studies have shown that narrower claims are associated with a higher probability of grant and shorter examination processes[3].

Key Takeaways

  • Patent Claims: The claims of a patent define its scope and are crucial for determining the protection granted.
  • Patent Landscape: Understanding related patents and the broader patent landscape is essential for navigating intellectual property.
  • Valuation: Patents can be highly valuable, with their worth determined by cost, income, and market approaches.
  • Patent Term: The term of a patent is generally 20 years from the effective filing date, with possible adjustments.
  • Technological Trends: Patents reflect ongoing innovation in various technological fields, including pharmaceuticals.
  • Global Trends: Patenting trends are part of a global landscape, with international classifications facilitating comparisons.

FAQs

Q: What is the primary purpose of the claims in a patent? A: The primary purpose of the claims in a patent is to define the scope of protection granted to the inventor.

Q: How is the value of a patent typically determined? A: The value of a patent is typically determined using the cost, income, and market approaches.

Q: What is the general term of a utility patent in the United States? A: The general term of a utility patent in the United States is 20 years from the effective filing date.

Q: Why are narrower claims often preferred in patent applications? A: Narrower claims are often preferred because they are associated with a higher probability of grant and shorter examination processes.

Q: How do global patent trends influence innovation? A: Global patent trends reflect and influence innovation by providing indicators of technological advancements and competitive landscapes across different countries.

Sources

  1. The Value of a Patent - Perpetual Motion Patents
  2. ALLERGAN USA, INC. v. MSN LABORATORIES PRIVATE LTD. - United States Court of Appeals for the Federal Circuit
  3. Patent Claims and Patent Scope - SSRN
  4. Invention: U.S. and Comparative Global Trends - National Science Foundation
  5. MORGAN, LEWIS & BOCKIUS LLP - Insight.RPXCorp.com

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,945,960

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Purple Biotech CONSENSI amlodipine besylate; celecoxib TABLET;ORAL 210045-001 May 31, 2018 DISCN Yes No 10,945,960 ⤷  Subscribe Y ⤷  Subscribe
Purple Biotech CONSENSI amlodipine besylate; celecoxib TABLET;ORAL 210045-002 May 31, 2018 DISCN Yes No 10,945,960 ⤷  Subscribe Y ⤷  Subscribe
Purple Biotech CONSENSI amlodipine besylate; celecoxib TABLET;ORAL 210045-003 May 31, 2018 DISCN Yes No 10,945,960 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,945,960

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 111065382 ⤷  Subscribe
World Intellectual Property Organization (WIPO) 2019008583 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.